|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-5-7
|
|
pubmed:abstractText |
The purpose of this study was to assess the feasibility of using rare event imaging system (REIS)-assisted analysis to detect occult tumor cells (OTCs) in peripheral blood (PB). The study also sought to determine whether REIS-assisted OTC detection presents a clinically viable alternative to manual microscopic detection to establish the true significance of OTC from solid epithelial tumors.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:BergsrudDanielle EDE,
pubmed-author:BrunelleStephanieS,
pubmed-author:ChenLan BoLB,
pubmed-author:DahlTomT,
pubmed-author:EvenGaelleG,
pubmed-author:GaligerKevinK,
pubmed-author:HarrisLyndsayL,
pubmed-author:HerlitzAnnaA,
pubmed-author:KestersonJohnJ,
pubmed-author:KraeftStine-KathreinSK,
pubmed-author:LadanyiAndrasA,
pubmed-author:SalgiaRaviR,
pubmed-author:SherAndrew CAC
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3020-8
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:15131038-Breast Neoplasms,
pubmed-meshheading:15131038-Carcinoma, Small Cell,
pubmed-meshheading:15131038-Cell Count,
pubmed-meshheading:15131038-Cell Line, Tumor,
pubmed-meshheading:15131038-Humans,
pubmed-meshheading:15131038-Image Processing, Computer-Assisted,
pubmed-meshheading:15131038-Immunohistochemistry,
pubmed-meshheading:15131038-Keratins,
pubmed-meshheading:15131038-Lung Neoplasms,
pubmed-meshheading:15131038-Microscopy, Fluorescence,
pubmed-meshheading:15131038-Neoplastic Cells, Circulating,
pubmed-meshheading:15131038-Reproducibility of Results,
pubmed-meshheading:15131038-Sensitivity and Specificity
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Reliable and sensitive identification of occult tumor cells using the improved rare event imaging system.
|
|
pubmed:affiliation |
Department of Cancer Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|
